Pd22-05 Robotic Percutaneous Nephrolithotomy (Pcnl): The Initial Clinical Experience

You have accessJournal of UrologySurgical Technology 11 patients were discharged after an overnight stay. On POD 30, significant stone burden reduction (73% to 100%) was observed, with five patients completely stone-free (Grade A, 35.71%), one Grade B (7.10%), and two Grade C (14.20%). Two patients presented with grade 1 (1 UTI and 1 PULS 2 ureteral wall injury), and 1 patient presented with a grade 2 Clavien Dindo surgical complication. There were no robotic device-related adverse events. CONCLUSIONS: We report the world's first-in-human study of robotic-assisted mini-PCNL demonstrated the safety, efficacy, and feasibility of robotic—assisted PCNL across a wide range of clinical stone burden scenarios. Source of Funding: This clinical trial was sponsored by Johnson & Johnson © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e462 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Jaime Landman More articles by this author Mihir Desai More articles by this author Roshan M. Patel More articles by this author Pengbo Jiang More articles by this author Andrei D. Cumpanas More articles by this author Nancy Sehgel More articles by this author Jacob W. Caldwell More articles by this author Chiara Gatti More articles by this author William J. Petraiuolo More articles by this author Paul T. Morris More articles by this author Ralph V. Clayman More articles by this author Expand All Advertisement PDF downloadLoading ...